Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept (Q34595156)

3 August 2017

1 reference

title

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept (English)

1 reference

3 August 2017

Roy Fleischmann

1

1 reference

3 August 2017

Imran Iqbal

series ordinal

2

1 reference

3 August 2017

Pallavi Nandeshwar

series ordinal

3

1 reference

3 August 2017

Andres Quiceno

series ordinal

4

1 reference

3 August 2017

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

25

1 reference

3 August 2017

3

1 reference

3 August 2017

173-197

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200225030-00004

3 August 2017

0 references

cites work

Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.

1 reference

12 December 2020

Epidemiology of rheumatoid arthritis: update

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

12 December 2020

Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

1 reference

12 December 2020

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

12 December 2020

Preliminary definition of improvement in juvenile arthritis

1 reference

12 December 2020

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

1 reference

12 December 2020

Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression

1 reference

12 December 2020

Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study

1 reference

12 December 2020

Epidemiology of rheumatic diseases

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study

1 reference

12 December 2020

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

12 December 2020

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

12 December 2020

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

12 December 2020

Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone

1 reference

12 December 2020

What happens to patients with rheumatoid arthritis? The long-term outcome of treatment

1 reference

12 December 2020

Anti-cytokine therapy for rheumatoid arthritis

1 reference

12 December 2020

Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study

1 reference

12 December 2020

Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy

1 reference

12 December 2020

A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis

1 reference

12 December 2020

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)

1 reference

12 December 2020

The treatment of rheumatic polyarthritis with acid azo compounds

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis

1 reference

12 December 2020

Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis?

1 reference

12 December 2020

[Rheumatoid arthritis. Therapeutic efficacy of methotrexate and its hepatotoxic effects]

1 reference

12 December 2020

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

12 December 2020

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

12 December 2020

Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

1 reference

12 December 2020

Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study

1 reference

12 December 2020

Patients receiving etanercept may develop antibodies that interfere with monoclonal antibody laboratory assays

1 reference

12 December 2020

Leukocytoclastic vasculitis due to etanercept

1 reference

12 December 2020

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

1 reference

12 December 2020

Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety

1 reference

12 December 2020

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

1 reference

12 December 2020

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

12 December 2020

Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation

1 reference

12 December 2020

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.

1 reference

12 December 2020

Salazopyrin in the Treatment of Rheumatoid Arthritis

1 reference

12 December 2020

Adverse events in methotrexate-treated rheumatoid arthritis patients.

1 reference

12 December 2020

Salazopyrin in rheumatoid arthritis

1 reference

12 December 2020

Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

12 December 2020

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

Toxicity of methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

12 December 2020

The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Survival in rheumatoid arthritis

1 reference

12 December 2020

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

1 reference

12 December 2020

The epidemiology of drug treatment failure in rheumatoid arthritis

1 reference

12 December 2020

Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States

1 reference

12 December 2020

Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis

1 reference

12 December 2020

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

12 December 2020

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

1 reference

12 December 2020

The facts about methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in refractory rheumatoid arthritis

1 reference

12 December 2020

Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study

1 reference

12 December 2020

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis

1 reference

12 December 2020

Methotrexate use in rheumatoid arthritis

1 reference

12 December 2020

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells

1 reference

12 December 2020

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

12 December 2020

Gold salts in the treatment of rheumatoid arthritis. A double-blind study

1 reference

12 December 2020

Sulfasalazine. Adverse effects and desensitization

1 reference

12 December 2020

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

12 December 2020

Methotrexate treatment of rheumatoid arthritis: effects on radiological progression

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

1 reference

12 December 2020

Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities

1 reference

12 December 2020

Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study

1 reference

12 December 2020

Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis

1 reference

12 December 2020

Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group

1 reference

12 December 2020

Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis

1 reference

12 December 2020

The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

12 December 2020

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

10.2165/00002018-200225030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference